|
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
|
journal
|
February 2019 |
|
A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
|
journal
|
October 2009 |
|
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
|
journal
|
September 2020 |
|
An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections
|
journal
|
September 2019 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
|
journal
|
February 2021 |
|
Cedar Virus: A Novel Henipavirus Isolated from Australian Bats
|
journal
|
August 2012 |
|
Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody
|
journal
|
October 2013 |
|
A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge
|
journal
|
August 2012 |
|
A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge
|
journal
|
October 2011 |
|
SWISS-MODEL: homology modelling of protein structures and complexes
|
journal
|
May 2018 |
|
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
|
journal
|
August 2021 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
A new Hendra virus genotype found in Australian flying foxes
|
journal
|
October 2021 |
|
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
|
journal
|
November 2019 |
|
Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine
|
journal
|
December 2006 |
|
Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form
|
journal
|
December 2015 |
|
Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly
|
journal
|
December 2015 |
|
Privateer: software for the conformational validation of carbohydrate structures
|
journal
|
November 2015 |
|
Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species
|
journal
|
March 2018 |
|
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
|
journal
|
November 2020 |
|
From The Cover: Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
|
journal
|
July 2005 |
|
Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation
|
journal
|
October 2017 |
|
Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2
|
journal
|
May 2008 |
|
Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus
|
journal
|
September 2019 |
|
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study
|
journal
|
April 2020 |
|
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
|
journal
|
April 2021 |
|
Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera
|
journal
|
December 2019 |
|
Towards automated crystallographic structure refinement with phenix.refine
|
journal
|
March 2012 |
|
Vaccines to Emerging Viruses: Nipah and Hendra
|
journal
|
September 2020 |
|
Broad sarbecovirus neutralization by a human monoclonal antibody
|
journal
|
July 2021 |
|
Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody
|
journal
|
June 2014 |
|
Exceptionally Potent Cross‐Reactive Neutralization of Nipah and Hendra Viruses by a Human Monoclonal Antibody
|
journal
|
March 2008 |
|
Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health
|
journal
|
March 2014 |
|
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
|
journal
|
July 2021 |
|
MolProbity: More and better reference data for improved all-atom structure validation: PROTEIN SCIENCE.ORG
|
journal
|
November 2017 |
|
Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo
|
journal
|
September 2015 |
|
Cathepsin L Is Involved in Proteolytic Processing of the Hendra Virus Fusion Protein
|
journal
|
September 2005 |
|
Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia
|
journal
|
March 2022 |
|
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex
|
journal
|
November 2019 |
|
Hendra and Nipah viruses: different and dangerous
|
journal
|
January 2006 |
|
Functional studies of host-specific ephrin-B ligands as Henipavirus receptors
|
journal
|
March 2008 |
|
A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L
|
journal
|
March 2006 |
|
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
|
journal
|
July 2005 |
|
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein
|
journal
|
December 2020 |
|
Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3
|
journal
|
July 2008 |
|
Architecture and antigenicity of the Nipah virus attachment glycoprotein
|
journal
|
March 2022 |
|
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
|
journal
|
November 2020 |
|
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
|
journal
|
August 2021 |